Cargando…

ST‐Segment–Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors—How Common Are They, and What Are Their Outcomes?

BACKGROUND: Programs targeting the standard modifiable cardiovascular risk factors (SMuRFs: hypertension, diabetes mellitus, hypercholesterolemia, smoking) are critical to tackling coronary heart disease at a community level. However, myocardial infarction in SMuRF‐less individuals is not uncommon....

Descripción completa

Detalles Bibliográficos
Autores principales: Vernon, Stephen T., Coffey, Sean, D'Souza, Mario, Chow, Clara K., Kilian, Jens, Hyun, Karice, Shaw, James A., Adams, Mark, Roberts‐Thomson, Philip, Brieger, David, Figtree, Gemma A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898813/
https://www.ncbi.nlm.nih.gov/pubmed/31672080
http://dx.doi.org/10.1161/JAHA.119.013296
_version_ 1783477031706558464
author Vernon, Stephen T.
Coffey, Sean
D'Souza, Mario
Chow, Clara K.
Kilian, Jens
Hyun, Karice
Shaw, James A.
Adams, Mark
Roberts‐Thomson, Philip
Brieger, David
Figtree, Gemma A.
author_facet Vernon, Stephen T.
Coffey, Sean
D'Souza, Mario
Chow, Clara K.
Kilian, Jens
Hyun, Karice
Shaw, James A.
Adams, Mark
Roberts‐Thomson, Philip
Brieger, David
Figtree, Gemma A.
author_sort Vernon, Stephen T.
collection PubMed
description BACKGROUND: Programs targeting the standard modifiable cardiovascular risk factors (SMuRFs: hypertension, diabetes mellitus, hypercholesterolemia, smoking) are critical to tackling coronary heart disease at a community level. However, myocardial infarction in SMuRF‐less individuals is not uncommon. This study uses 2 sequential large, multicenter registries to examine the proportion and outcomes of SMuRF‐less ST‐segment–elevation myocardial infarction (STEMI) patients. METHODS AND RESULTS: We identified 3081 STEMI patients without a prior history of cardiovascular disease in the Australian GRACE (Global Registry of Acute Coronary Events) and CONCORDANCE (Cooperative National Registry of Acute Coronary Syndrome Care) registries, encompassing 42 hospitals, between 1999 and 2017. We examined the proportion that were SMuRF‐less as well as outcomes. The primary outcome was in‐hospital mortality, and the secondary outcome was major adverse cardiovascular events (death, myocardial infarction, or heart failure, during the index admission). Multivariate regression models were used to identify predictors of major adverse cardiovascular events. Of STEMI patients without a prior history of cardiovascular disease 19% also had no history of SMuRFs. This proportion increased from 14% to 23% during the study period (P=0.0067). SMuRF‐less individuals had a higher in‐hospital mortality rate than individuals with 1 or more SMuRFs. There were no clinically significant differences in major adverse cardiovascular events at 6 months between the 2 groups. CONCLUSIONS: A substantial and increasing proportion of STEMI presentations occur independently of SMuRFs. Discovery of new markers and mechanisms of disease beyond standard risk factors may facilitate novel preventative strategies. Studies to assess longer‐term outcomes of SMuRF‐less STEMI patients are warranted.
format Online
Article
Text
id pubmed-6898813
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68988132019-12-16 ST‐Segment–Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors—How Common Are They, and What Are Their Outcomes? Vernon, Stephen T. Coffey, Sean D'Souza, Mario Chow, Clara K. Kilian, Jens Hyun, Karice Shaw, James A. Adams, Mark Roberts‐Thomson, Philip Brieger, David Figtree, Gemma A. J Am Heart Assoc Original Research BACKGROUND: Programs targeting the standard modifiable cardiovascular risk factors (SMuRFs: hypertension, diabetes mellitus, hypercholesterolemia, smoking) are critical to tackling coronary heart disease at a community level. However, myocardial infarction in SMuRF‐less individuals is not uncommon. This study uses 2 sequential large, multicenter registries to examine the proportion and outcomes of SMuRF‐less ST‐segment–elevation myocardial infarction (STEMI) patients. METHODS AND RESULTS: We identified 3081 STEMI patients without a prior history of cardiovascular disease in the Australian GRACE (Global Registry of Acute Coronary Events) and CONCORDANCE (Cooperative National Registry of Acute Coronary Syndrome Care) registries, encompassing 42 hospitals, between 1999 and 2017. We examined the proportion that were SMuRF‐less as well as outcomes. The primary outcome was in‐hospital mortality, and the secondary outcome was major adverse cardiovascular events (death, myocardial infarction, or heart failure, during the index admission). Multivariate regression models were used to identify predictors of major adverse cardiovascular events. Of STEMI patients without a prior history of cardiovascular disease 19% also had no history of SMuRFs. This proportion increased from 14% to 23% during the study period (P=0.0067). SMuRF‐less individuals had a higher in‐hospital mortality rate than individuals with 1 or more SMuRFs. There were no clinically significant differences in major adverse cardiovascular events at 6 months between the 2 groups. CONCLUSIONS: A substantial and increasing proportion of STEMI presentations occur independently of SMuRFs. Discovery of new markers and mechanisms of disease beyond standard risk factors may facilitate novel preventative strategies. Studies to assess longer‐term outcomes of SMuRF‐less STEMI patients are warranted. John Wiley and Sons Inc. 2019-11-01 /pmc/articles/PMC6898813/ /pubmed/31672080 http://dx.doi.org/10.1161/JAHA.119.013296 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Vernon, Stephen T.
Coffey, Sean
D'Souza, Mario
Chow, Clara K.
Kilian, Jens
Hyun, Karice
Shaw, James A.
Adams, Mark
Roberts‐Thomson, Philip
Brieger, David
Figtree, Gemma A.
ST‐Segment–Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors—How Common Are They, and What Are Their Outcomes?
title ST‐Segment–Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors—How Common Are They, and What Are Their Outcomes?
title_full ST‐Segment–Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors—How Common Are They, and What Are Their Outcomes?
title_fullStr ST‐Segment–Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors—How Common Are They, and What Are Their Outcomes?
title_full_unstemmed ST‐Segment–Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors—How Common Are They, and What Are Their Outcomes?
title_short ST‐Segment–Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors—How Common Are They, and What Are Their Outcomes?
title_sort st‐segment–elevation myocardial infarction (stemi) patients without standard modifiable cardiovascular risk factors—how common are they, and what are their outcomes?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898813/
https://www.ncbi.nlm.nih.gov/pubmed/31672080
http://dx.doi.org/10.1161/JAHA.119.013296
work_keys_str_mv AT vernonstephent stsegmentelevationmyocardialinfarctionstemipatientswithoutstandardmodifiablecardiovascularriskfactorshowcommonaretheyandwhataretheiroutcomes
AT coffeysean stsegmentelevationmyocardialinfarctionstemipatientswithoutstandardmodifiablecardiovascularriskfactorshowcommonaretheyandwhataretheiroutcomes
AT dsouzamario stsegmentelevationmyocardialinfarctionstemipatientswithoutstandardmodifiablecardiovascularriskfactorshowcommonaretheyandwhataretheiroutcomes
AT chowclarak stsegmentelevationmyocardialinfarctionstemipatientswithoutstandardmodifiablecardiovascularriskfactorshowcommonaretheyandwhataretheiroutcomes
AT kilianjens stsegmentelevationmyocardialinfarctionstemipatientswithoutstandardmodifiablecardiovascularriskfactorshowcommonaretheyandwhataretheiroutcomes
AT hyunkarice stsegmentelevationmyocardialinfarctionstemipatientswithoutstandardmodifiablecardiovascularriskfactorshowcommonaretheyandwhataretheiroutcomes
AT shawjamesa stsegmentelevationmyocardialinfarctionstemipatientswithoutstandardmodifiablecardiovascularriskfactorshowcommonaretheyandwhataretheiroutcomes
AT adamsmark stsegmentelevationmyocardialinfarctionstemipatientswithoutstandardmodifiablecardiovascularriskfactorshowcommonaretheyandwhataretheiroutcomes
AT robertsthomsonphilip stsegmentelevationmyocardialinfarctionstemipatientswithoutstandardmodifiablecardiovascularriskfactorshowcommonaretheyandwhataretheiroutcomes
AT briegerdavid stsegmentelevationmyocardialinfarctionstemipatientswithoutstandardmodifiablecardiovascularriskfactorshowcommonaretheyandwhataretheiroutcomes
AT figtreegemmaa stsegmentelevationmyocardialinfarctionstemipatientswithoutstandardmodifiablecardiovascularriskfactorshowcommonaretheyandwhataretheiroutcomes